The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Findings from the field of evolutionary biology are yielding dramatic insights for health
scientists, especially those involved in the fight against infectious diseases. This book is the …

In 2012, the number of people infected with human T cell lymphotropic virus type 1 (HTLV-1)
was estimated to be 10 million worldwide. Prevalence varies according to geographic …

To investigate the role of viral expression in individuals infected with human T-cell
lymphotropic virus type 1 (HTLV-1), a real-time quantitative reverse transcription-polymerase …

The association between human T cell lymphotropic virus (HTLV) type I tax variation and
disease outcome was studied. The tax gene was sequenced in 61 patients with HTLV-I …

Human T lymphocyte virus type I (HTLV-I)–associated chronic inflammatory neurological
disease (HTLV-I–associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is …

This narrative review, which is based on a systematic literature search following the PRISMA
guidelines, provides a general overview of Human T‐cell Lymphotropic Virus type 1 (HTLV …

To determine the epidemiological characteristics of human T cell leukemia/lymphoma virus
type I (HTLV‐I) infection in the endemic village of Maripasoula, French Guiana, 1,614 …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

Introducción. El virus linfotrópico de células T humanas (HTLV) de tipos 1 y 2 ocasiona
trastornos clínicos asociados a enfermedades degenerativas y proliferativas. Entre sus …